🏅 FDA Orphan Designation

Cafcit

Caffeine

Manufacturer: O.P.R. Development, L.P.

Indicated for:

Apnea of prematurityOrphan

FDA-Approved Indications (1)

Apnea of prematurityOrphan Designation

Short term treatment of apnea of prematurity in infants between 28 and less than 33 weeks gestational age.

Indications & Usage

INDICATIONS AND USAGE CAFCIT (caffeine citrate) is indicated for the treatment of apnea of prematurity.

💙 Support Programs

View all →

Butalbital/Acetaminophen/Caffeine

Teva

Orphenadrine Citrate, Aspirin and Caffeine

Galt Pharmaceuticals

Copay card ↗Apply ↗

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate

Teva

Butalbital, Acetaminophen, Caffeine

AbbVie

Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.